{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:04:01Z","timestamp":1761807841178,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.canrad.2013.01.021","type":"journal-article","created":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T14:46:23Z","timestamp":1369406783000},"page":"272-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Analyse des r\u00e9sultats d\u2019une s\u00e9rie de 20\u00a0patients trait\u00e9s par irradiation hypofractionn\u00e9e en conditions st\u00e9r\u00e9otaxiques par Novalis Tx\u00ae pour un cancer bronchopulmonaire non \u00e0 petites cellules de stade I"],"prefix":"10.1016","volume":"17","author":[{"given":"F.","family":"Guillerme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-B.","family":"Clavier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-E.","family":"Falcoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Bourrhala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Santelmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hassler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9.","family":"Quoix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Massard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2013.01.021_bib0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ssu.10024","article-title":"Surgery for early stage non-small cell lung cancer","volume":"21","author":"Chang","year":"2003","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0010","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.clon.2008.06.005","article-title":"Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer","volume":"20","author":"Brock","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.canrad.2013.01.021_bib0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijrobp.2007.10.053","article-title":"Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer","volume":"70","author":"Lagerwaard","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.01.021_bib0020","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1200\/JCO.2008.21.5681","article-title":"Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy","volume":"27","author":"Baumann","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0250","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2013.01.021_bib0030","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1200\/JCO.2010.30.3271","article-title":"European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer","volume":"28","author":"De Ruysscher","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/PPO.0b013e31820a7f80","article-title":"Stereotactic ablative radiation therapy for primary lung tumors","volume":"17","author":"Heinzerling","year":"2011","journal-title":"Cancer J"},{"key":"10.1016\/j.canrad.2013.01.021_bib0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.canrad.2009.07.039","article-title":"\u00b7Analyse des contraintes dosim\u00e9triques obtenues par trois techniques d\u2019irradiation de tumeurs pulmonaires","volume":"14","author":"Beneyton","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2013.01.021_bib0045","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0360-3016(00)00750-1","article-title":"Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning","volume":"48","author":"Giraud","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.01.021_bib0050","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/icvts\/ivs423","article-title":"Is radiofrequency ablation or stereotactic ablative radiotherapy the best treatment for radically treatable primary lung cancer unfit for surgery?","volume":"16","author":"Renaud","year":"2013","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.canrad.2013.01.021_bib0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1634\/theoncologist.2007-0195","article-title":"Critical review of non-surgical treatment options for stage I non-small cell lung cancer","volume":"13","author":"Haasbeek","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.canrad.2013.01.021_bib0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.canrad.2012.07.184","article-title":"Maladie oligom\u00e9tastatique, un nouveau concept\u00a0: irradiation en conditions st\u00e9r\u00e9otaxiques de m\u00e9tastases pulmonaires. Revue de la litt\u00e9rature","volume":"16","author":"Hatime","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2013.01.021_bib0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000324113","article-title":"Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidity","volume":"4","author":"Turzer","year":"2011","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0075","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jnci\/djn175","article-title":"Evaluation of trends in the cost of initial cancer treatment","volume":"100","author":"Warren","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2013.01.021_bib0080","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/annonc\/mdp360","article-title":"EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts\u2019 opinion for the treatment of non-small-cell lung cancer in an elderly population","volume":"21","author":"Pallis","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0085","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1164\/rccm.200907-1064OC","article-title":"Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer","volume":"181","author":"Wisnivesky","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.canrad.2013.01.021_bib0090","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1200\/JCO.2010.30.0731","article-title":"Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis","volume":"28","author":"Palma","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0095","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2012.07.2354","article-title":"Comparative effectiveness of 5\u00a0treatment strategies for early-stage non-small cell lung cancer in the elderly","volume":"84","author":"Shirvani","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.01.021_bib0100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/cncr.24759","article-title":"nonsmall cell lung cancer in patients aged>or=75\u00a0years: outcomes after stereotactic radiotherapy","volume":"116","author":"Haasbeek","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2013.01.021_bib0105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2011.06.029","article-title":"Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery","volume":"101","author":"Palma","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijrobp.2006.04.013","article-title":"Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I\/II non-small-cell lung cancer","volume":"66","author":"Xia","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.01.021_bib0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1748-717X-3-36","article-title":"Normal tissue toxicity after small field hypofractionated stereotactic body radiation","volume":"3","author":"Milano","year":"2008","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0120","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1378\/chest.124.5.1946","article-title":"Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer","volume":"124","author":"Timmerman","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.canrad.2013.01.021_bib0125","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0130","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01243894-200610000-00008","article-title":"Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors","volume":"1","author":"Le","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0135","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/02841860600913210","article-title":"Stereotactic hypofractionated radiotherapy in stage I (T1-2\u00a0N0\u00a0M0) non-small-cell lung cancer (NSCLC)","volume":"45","author":"Zimmermann","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0140","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ijrobp.2010.07.025","article-title":"Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50\u00a0patients","volume":"81","author":"Palma","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.01.021_bib0145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.radonc.2007.10.044","article-title":"Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study","volume":"85","author":"Guckenberger","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1748-717X-2-21","article-title":"Exceptionally high incidence of symptomatic grade 2-5\u00a0radiation pneumonitis after stereotactic radiation therapy for lung tumors","volume":"2","author":"Yamashita","year":"2007","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijrobp.2010.08.056","article-title":"A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy","volume":"82","author":"Barriger","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.01.021_bib0160","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.ijrobp.2012.01.018","article-title":"Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer","volume":"83","author":"Matsuo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.01.021_bib0165","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ijrobp.2011.11.080","article-title":"Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors","volume":"84","author":"Diot","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.01.021_bib0170","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ijrobp.2011.03.005","article-title":"Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review","volume":"82","author":"Palma","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.01.021_bib0175","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1097\/JTO.0b013e3182307e74","article-title":"Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer","volume":"6","author":"Bongers","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0180","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ijrobp.2010.03.020","article-title":"Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver","volume":"80","author":"Andolino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.01.021_bib0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1748-717X-6-137","article-title":"Rib fracture after stereotactic radiotherapy on follow-up thin-section computed tomography in 177\u00a0primary lung cancer patients","volume":"6","author":"Nambu","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.radonc.2012.01.014","article-title":"Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy","volume":"104","author":"Creach","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0195","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijrobp.2011.06.1971","article-title":"Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes","volume":"83","author":"Woody","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.01.021_bib0200","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.athoracsur.2009.05.040","article-title":"Survival of patients with true pathologic stage I non-small cell lung cancer","volume":"88","author":"Cerfolio","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.canrad.2013.01.021_bib0205","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lungcan.2011.07.018","article-title":"PET scans in radiotherapy planning of lung cancer","volume":"75","author":"De Ruysscher","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2013.01.021_bib0210","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2011.10.016","article-title":"Mediastinal lymph nodes staging by 18F-FDG PET\/CT for early stage non-small cell lung cancer: a multicenter study","volume":"102","author":"Li","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2009.12.008","article-title":"Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications","volume":"94","author":"Chi","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0220","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.radonc.2011.08.008","article-title":"The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT)","volume":"101","author":"Takeda","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0225","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2012.04.019","article-title":"Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): is FDG-PET a predictor of outcome?","volume":"104","author":"Clarke","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0230","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/j.ijrobp.2012.01.012","article-title":"Residual (18)F-FDG-PET uptake 12\u00a0weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control","volume":"83","author":"Bollineni","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.01.021_bib0235","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1200\/JCO.2009.25.0928","article-title":"Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer","volume":"28","author":"Grills","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/JTO.0b013e3181c20080","article-title":"Timing of local and distant failure in resected lung cancer: implications for reported rates of local failure","volume":"5","author":"Boyd","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2013.01.021_bib0245","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ijrobp.2010.06.040","article-title":"Stereotactic body radiotherapy versus surgery for medically operable stage I non-small-cell lung cancer: a markov model-based decision analysis","volume":"81","author":"Louie","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321813000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321813000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:20:10Z","timestamp":1761135610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321813000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1278321813000759"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2013.01.021","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analyse des r\u00e9sultats d\u2019une s\u00e9rie de 20\u00a0patients trait\u00e9s par irradiation hypofractionn\u00e9e en conditions st\u00e9r\u00e9otaxiques par Novalis Tx\u00ae pour un cancer bronchopulmonaire non \u00e0 petites cellules de stade I","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2013.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}